Kawai Keisuke, Kojima Yuka, Yamamoto Yurie, Fujimoto Koji, Tamura Naho, Oya Toshiki, Tachimori Hisateru
Department of Psychosomatic Medicine, Kohnodai Hospital, National Center for Global Health Medicine, Chiba, Japan.
Chiba Prefecture Support Center for Eating disorders, Chiba, Japan.
Glob Health Med. 2022 Jun 30;4(3):152-158. doi: 10.35772/ghm.2021.01104.
We investigated the impact of medical collaboration between the Chiba Eating Disorder (ED) Treatment Support Center (CSC) in Chiba Prefecture and the ED treatment center at Kohnodai Hospital. We calculated the number of consultations performed by the CSC and referral rate to other medical facilities from October 2017 to March 2020, as well as the clinical characteristics of the patients treated at our hospital from April 2016 to March 2020. Data on duration of hospitalization and increase in body mass index (BMI) during hospitalization were recorded. Patients were divided into all of the Japan and Chiba Prefecture groups. Data were evaluated by Poisson's regression analysis or one-way analysis of variance. A -value < 0.05 was considered significant. The 2019 data served as reference values. Our data demonstrated that while the number of CSC consultations increased (2017:201, 2018:547, 2019:552) annually, the number of hospitalizations for EDs decreased (197, 194, 134, respectively). In comparison, the number of outpatient consultations for EDs across all of Japan peaked in 2018 and decreased significantly thereafter (2016:110, 2017:139, 2018:193, 2019:142). After the CSC was established, the number of patients treated in our department decreased as expected. Patients with anorexia nervosa (AN) who were treated on an outpatient basis across all of Japan were younger in 2019 (27.0 ± 1.2) than in 2018 (31.9 ± 1.2). Severe cases had better outcomes, and there was a significant increase in BMI of inpatients with AN in both groups. Overall, the activities of such ED treatment support center promoted successful treatment of severe ED cases.
我们调查了千叶县千叶饮食失调（ED）治疗支持中心（CSC）与小实医院ED治疗中心之间医疗合作的影响。我们计算了2017年10月至2020年3月CSC进行的会诊次数以及转诊至其他医疗机构的比率，以及2016年4月至2020年3月在我院接受治疗患者的临床特征。记录了住院时间和住院期间体重指数（BMI）增加的数据。患者分为全日本组和千叶县组。数据通过泊松回归分析或单因素方差分析进行评估。P值<0.05被认为具有统计学意义。2019年的数据作为参考值。我们的数据表明，虽然CSC的会诊次数逐年增加（2017年：201次，2018年：547次，2019年：552次），但ED的住院人数却有所下降（分别为197例、194例、134例）。相比之下，全日本ED的门诊会诊次数在2018年达到峰值，此后显著下降（2016年：110次，2017年：139次，2018年：193次，2019年：142次）。CSC成立后，我科治疗的患者数量如预期减少。2019年全日本门诊治疗的神经性厌食症（AN）患者比2018年（31.9±1.2）更年轻（27.0±1.2）。重症病例预后较好，两组AN住院患者的BMI均显著增加。总体而言，此类ED治疗支持中心的活动促进了重症ED病例的成功治疗。
